COVID-19 Critical Care

August 14, 2020

Date & Location:

12 week program ( May 26 - August 14, 2020)


In keeping with the expected competencies of patient care, medical knowledge, system-based practice, practice-based learning, professionalism, interpersonal and communication skills we aim to provide learners with a high-quality curriculum for APPs practicing in the COVID-19 Critical Care Units where we are able to facilitate their learning and enhance their critical care skill set. 
1.  To teach APPs how to evaluate and formulate a thoughtful management plan for critically ill patients with COVID-19
2.  To create an evidence-based critical care educational resources that augments APP's bedside training in the fundamentals of critical care medicine.
3.  To prepare competent compassionate health professionals who will be equipped to care for the critically ill and their families

Provided by:

Pulmonary and Critical Care Medicine and Baystate Continuing Interprofessional Education

Target Audience

This course is designed for Apps and NPs

Learning Objectives

The Learning Objectives for the individual sessions are below:

Week 2 &3 Time to Vent Module 6/1/2020- 6/14/2020 (30 hrs)

  • Principles of Mechanical Ventilation
  • Simulation session: Mechanical Ventilators
  • Ventilator cases
  • Acute Respiratory Distress Syndrome

    Learning Objectives:
  • Accurately define the key terminology concerning mechanical ventilation as outlined by the learning activity and handout review.
  • List the similarities and differences among the most commonly used modes of mechanical ventilation.
  • Methodically interpret arterial blood gases and propose the necessary changes on a ventilator needed to treat the patient’s underlying pathologic process.
  • Describe what initiates the breath (trigger) and what terminates the breath (cycling) in mechanical ventilation.
  • Demonstrate a safety focused attitude by utilizing a low tidal volume lung protective strategy on patients with acute respiratory distress syndrome (ARDS) or those at risk of ARDS. 

    Week 4 & 5 Circulatory Shock: 6/15-6/28/2020 (30hrs)
  • Diagnosis and Hemodynamic monitoring
  • Hemodynamics and Flotrac
  • Vasoactive agents
  • Simulation session: Central line placement/scrubbing and gowning
  • Simulation session ABGs and arterial line placement

    Learning Objectives:
  • Accurately define circulatory shock.
  • Outline an approach to classify the categories of shock.
  • Describe the main components of hemodynamic monitoring.
  • Apply hemodynamics to determine the etiology of shock.
  • Describe the various methods of assessing fluid responsiveness in a critically ill patient.
  • Discuss the core strategies in managing critically ill patients with shock.
  • List the main effects and adverse effects of vasoactive agents.
  • Safely place a central line under supervision
  • Safely place an arterial line under supervision
  • Recall the steps involved in scrubbing and gowning for sterile procedures
  • Safely perform an arterial puncture under supervision

    Week 6 Sepsis in the ICU 6/29/2020-7/5/2020 (10 hrs)

    Learning Objectives:
  • Accurately define septic shock.
  • Outline an evidence-based approach to evaluate patients with suspected septic shock.
  • Describe the assessment of organ dysfunction by using the SOFA score.
  • Describe the first and second line vasopressors used in the management of patients with septic shock.
  • List the components of the sepsis care bundles as outlined by the surviving sepsis guidelines of 2018.
  • Summarize the role of lactic acid in predicting mortality in the setting of sepsis and septic shock.
  • Illustrate the ways in which volume status and tissue perfusion can be assessed in septic shock.

    Week 7 Analgesia, Sedation and Neuromuscular Blockade 7/6/2020-7/12/2020 (10hrs)
  • Analgesia, Sedation and Neuromuscular Blockade

    Learning Objectives:

  • Develop an analgesic strategy to treat patients in the critical care setting.
  • Evaluate both verbal and non-verbal ICU patients for pain using the Critical Care Pain Observation Tool (CPOT).
  • Evaluate both verbal and non-verbal ICU patients for agitation-sedation using the Richmond Agitation-Sedation Scale (RASS).
  • Summarize an ideal sedation strategy for critically ill patients based on the recommendations from the 2018 PADIS guidelines.
  • Describe the role of neuromuscular blockade in the ICU.
  • List the main short and long term adverse effects of commonly used analgesics, sedatives and neuromuscular blocking agents.

    Week 8 Delirium in the ICU 7/13/2020-7/19/2020 (10hrs)

    Learning Objectives:
  • Accurately define Delirium
  • List the risk factors for the development of ICU delirium
  • Apply the Confusion Assessment Method for Intensive Care Units (CAM- ICU) in identifying patients with delirium.
  • Devise a differential diagnosis for possible underlying etiologies of delirium in the critically ill patient
  • Describe both non-pharmacologic and pharmacologic strategies used in managing patients with delirium.

Summarize the components of the ABCDEF (A to F) Bundle including its role in improving patient outcomes.

Week 9 Acute Renal Failure in the ICU 7/20/2020-7/26/2020 (10 hrs)

Learning Objectives:

  • Accurately define Acute Kidney Injury.
  •  Describe the proposed pathophysiology of acute kidney Injury in COVID-19.
  • List the commonest causes of Acute Kidney Injury in the ICU.
  • Summarize the role of renal replacement therapy ( IHD, PIRRT and CVVH) in the treatment of renal failure in the critical care setting.
  • Identify patient who are at risk of renal failure.
  • Select strategies to prevent or mitigate the risk of acute renal failure.
  • Describe the postulated pathophysiology of AKI in the COVID-19 patient.​

Week 10 Critical Care Ultrasonography 7/27/2020-8/2/2020 (10hrs)

Learning Objectives:

  • Accurately compare the main indications and proper patient positioning when using the various ultrasound probes (linear, curvilinear, phased-array) in the critical care setting.
  • Differentiate between A-line, B-line artefacts and rib shadow
  • Identify the sonographic signs associated with pneumothorax, pleural effusion, pulmonary edema, and consolidation
  • Identify some sonographic features that are characteristic of transudative and exudative pleural effusions
  • Rapidly acquire ultrasound images of the heart, lungs and abdomen and distinguish between pathologic and normal studies.
  • Demonstrate the ability to survey the anatomy as it pertains to the two most commonly performed ultrasound guided invasive procedures in the ICU (central line placement, arterial line placement)
  • Identify at least one way that ultrasound makes the above procedures safer.
  • Appropriately identify patients in whom ultrasound will assist in diagnosis and clinical problem solving.
  • Interpret key findings and clinically relevant images in:
    1.  The Thorax
    2.  A Focused cardiac Exam
    3.  Inferior Vena Cava (volume assessment)
    4.  The assessment of peritoneal fluid (ascites)

Week 11 &12 Final week and CCAPP Presentations 8/3/2020-8/16/2020 (10hrs)

Learning Objectives

  • Describe how the six therapeutic agents' mechanism of action.
  • Summarize the evidence on the efficacy of the below therapeutic agents specifically in COVID-19.
  • State who would benefit the most form each of the therapeutic agents below.
  • Outline any adverse risks associated with each of the therapeutic modalities listed below.
    1.  Therapeutic agents:
    2.  Systemic Corticosteroids (Focus on Dexamethasone)
    3.  Antivirals (Focus on Remdesivir)
    4.  Convalescent Plasma
    5.  Anti-IL6 agents (Focus on Toclizumab)
    6.  Pulmonary Vasodilators (Focus on inhaled epoprostenol/ Flolan)​
    7.  Extracorporeal membrane oxygenation


Course summary
Available credit: 
  • 120.00 ANCC Contact Hours
Course opens: 
Course expires: 
Event starts: 
08/14/2020 - 3:00pm EDT
Event ends: 
08/14/2020 - 3:00pm EDT

Program Schedule 2020 

Week 1 - 05/26 - 05/31

Week 2 - 06/01 - 06/07
Time to Vent:  Principles of Mechanical VentilationSimulation session:  Mechanical Ventilators with Chris Frechette, RRT and Bogdan Tiru, MD

Week 3 - 06/08 -06/14
Time to Vent:  Acute Respiratory Distress SyndromeVentilator cases with Fahad Alroumi, MD

Week 4 - 06/15 - 06/21
Circulatory Shock:  Diagnosis and Hemodynamic Monitoring Hemodynamics and Flotrac with Dr. McGee - Simulation session:  Scrubbing / Gowning, ABGs and arterial line placement

Week 5 - 06/22 - 06/28
Circulatory Shock:  Vasoactive Agents Simulation session:  Central Line Placement

Week 6 - 06/29 - 07/05
Sepsis in the ICU

Week 7 - 07/06 - 07/12
Analgesia, Sedation and Neuromuscular Blockade    

Week 8 - 07/13 - 07/19
Agitation and Delirium

Week 9 - 07/20 - 07/26
Renal Failure in the ICU

Week 10 - 07/27 - 08/02
Critical Care Ultrasonography

Week 11 & 12 - 08/03 - 08/14
Final Week and CCAPP Presentations 


Faculty Disclosure

The design and content of Baystate Continuing Interprofessional Education (CE) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options. Faculty or planner conflicts of interest are resolved before the educational activity. 

None of the members of the faculty or planning committee have commercial relationships with commercial  companies providing goods or services used on patients.

United States

Meeting Room temperatures will fluctuate. 

Fahad Alroumi, MD, FCCP
Assistant Professor of Medicine
Pulmonary and Critical Care Medicine
UMMS - Baystate
Baystate Medical Center


The design and content of Baystate Continuing Interprofessional Education ( CE ) activities support quality improvement in healthcare and provide fair and balanced views of therapeutic options.  Faculty or planner conflicts of interest are resolved before the educational activity.

None of the members of the faculty or planning committee have commercial relationships with commercial  companies providing goods or services used on patients.

In support of improving patient care, Baystate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.







Available Credit

  • 120.00 ANCC Contact Hours


Please login or register to take this course.


Please Note:
  • Each participant must register themselves for the program
In order to receive CREDIT, the evaluation must be completed by:Thu, 12/31/2020 - 3:00pm

We appreciate your business and sincerely wish to meet your educational needs.  We understand that the schedule of a busy professional, like yourself, is subject to change.  Therefore, we have included information about our refund/cancellation policies for your convenience below.

If you must cancel, telephone Baystate Continuing Interprofessional Education at 413-322-4242 and follow your call with a written/email request.  All cancellations will incur a $25.00 fee.  Please note that we cannot refund cancellations received less than two weeks (10 business days) before the program date.

Refund Policy:
Your refund, less a cancellation fee, will be processed within two (2) weeks from the date we receive the written notification.  For credit card refunds, please allow one to two (1-2) billing cycles for the credit to appear on your statement.

Specific Aids or Services:
Please call Baystate Continuing Interprofessional Education at 413-322-4242 if, under the Americans with Disabilities Act, you require specific aids or services during your visit to this continuing education program.